Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 106Neoplasm Metastasis 7Neoplasms 5Breast Diseases 5Neoplasms by Site 4Ovarian Neoplasms 3Hereditary Sensory and Autonomic Neuropathies 3Carcinoma, Ovarian Epithelial 3Breast Neoplasms, Male 3Triple Negative Breast Neoplasms 2Multiple Endocrine Neoplasia Type 1 2Endometrial Neoplasms 2Breast Cancer Metastatic 2Anatomic Stage II Breast Cancer AJCC v8 2Advanced Breast Cancer 2Venous Thromboembolism 1Uterine Cervical Neoplasms 1Unilateral Breast Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Recurrence 1Osteitis Deformans 1Neoplastic Cells, Circulating 1Mesothelioma 1Lymphoma 1Lung Neoplasms 1Locoregional Recurrence 1Locally Advanced (Inoperable) or Metastatic Breast Cancer 1Leukemia 1Hormone Receptor Positive, HER2-negative, Advanced Breast Cancer 1Hematologic Neoplasms 1

Interventions

Lapatinib 2ribociclib 1Trastuzumab 1Paclitaxel 1Letrozole 1Goserelin 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Osteitis Deformans × ribociclib × Breast × Clear all
NCT03096847 2021-10-11

Study for Women and Men With Hormone-receptor Positive Locally Advanced or Metastatic Breast Cancer

Novartis

Phase 3 Completed
502 enrolled 20 charts
Breast

Breast Neoplasms, Osteitis Deformans

Data powered by HemOnc (CC BY 4.0) Colophon âš¡